* BIO-Key International Inc BKYI.OQ BKYI.O is expected
to show
a rise in quarterly revenue when it reports results on November
14.
* The Wall New Jersey New Jersey-based company is expected
to
report a 84.8% increase in revenue to $2.4 million from $1.3
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for BIO-Key
International Inc
is for a loss of 16 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $4, above its last closing price
of $1.44.
This summary was machine generated November 12 at 00:53 GMT.
All figures in US dollars unless otherwise stated